CIC
IMA

Cornercap Investment Counsel’s ImageneBio Inc IMA Stock Holding History

Cornercap Investment Counsel’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,013
Closed -$51.3K – 649
2024
Q1 		$51.3K Hold
3,013
– – 0.01% 588
2023
Q4 		$71.2K Sell
3,013
-91
-3% -$2.97K 0.01% 561
2023
Q3 		$161K Sell
3,104
-92
-3% -$5.54K 0.03% 506
2023
Q2 		$252K Sell
3,196
-92
-3% -$6.6K 0.04% 481
2023
Q1 		$136K Buy
3,288
+833
+34% +$38.3K 0.02% 530
2022
Q4 		$78.4K Hold
2,455
– – 0.01% 539
2022
Q3 		$105K Buy
2,455
+1,069
+77% +$61.8K 0.02% 525
2022
Q2 		$74K Buy
+1,386
New +$76.5K 0.01% 535

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cornercap Investment Counsel's IMA Position: Q2 2024 in Review

Cornercap Investment Counsel sold out of ImageneBio Inc (IMA) in Q2 2024, closing a stake of 3,013 shares — an estimated $51.3K sold.

Cornercap Investment Counsel first reported a position in IMA in Q2 2022 and held it in 8 quarters. The position peaked at $252K in Q2 2023. 70 funds tracked by Wall St. Rank hold IMA as of Q2 2024.

  • Cornercap Investment Counsel reported no remaining ImageneBio Inc position as of Q2 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 3,013 ImageneBio Inc shares in Q2 2024, an estimated $51.3K.
  • Cornercap Investment Counsel first reported a position in ImageneBio Inc in Q2 2022 and held it in 8 quarters.
  • Cornercap Investment Counsel's ImageneBio Inc position peaked at $252K in Q2 2023.
  • 70 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2024.

Based on Cornercap Investment Counsel's 13F filing for Q2 2024, filed 8 Aug 2024.